Actively Recruiting

Phase Not Applicable
Age: 16Years +
All Genders
ID05812950

Clinical and Cost-effectiveness of Group Schema Therapy for Complex Eating Disorders: the GST-EAT Study

Led by Maastricht University · Updated on 2023-11-30

230

Participants Needed

7

Research Sites

N/A

Total Duration

On this page

Sponsors

M

Maastricht University

Lead Sponsor

U

Utrecht University

Collaborating Sponsor

AI-Summary

What this Trial Is About

Eating disorders (EDs) are challenging psychiatric conditions with high mortality and often become chronic, lasting an average of six years. Comorbid personality issues like negative core beliefs and early maladaptive schemas (EMS) are strongly linked to the severity and persistence of EDs. While cognitive-behavioral therapy enhanced (CBT-E) is the standard first-line treatment focusing on symptoms, it does not address these underlying personality factors. This study aims to evaluate the clinical and cost-effectiveness of group schema therapy (GST) for ED patients with comorbid personality pathology who do not respond significantly to the initial phase of CBT-E, addressing a crucial gap in treatment options. Participants who have completed the first two phases of CBT-E but show limited improvement will be randomized to either continue CBT-E or start GST. GST begins with five individual sessions introducing the schema therapy model and organizing coping modes, followed by 26 weekly group sessions and up to eight optional individual sessions. A psycho-education webinar for relatives is also included. GST focuses on changing personal coping modes and early maladaptive schemas while supporting healthy adult mode development. CBT-E involves 20 to 40 weekly individual therapy sessions across four phases, targeting eating behavior patterns and relapse prevention. Throughout the study, participants will be assessed at multiple time points before, during, and after treatment, including up to 12 months post-treatment. Evaluations include questionnaires measuring eating disorder symptoms, schema-related beliefs, symptom inventories, quality of life, and treatment costs. These assessments aim to track changes in ED severity, personality pathology, and overall well-being. The study intends to provide evidence on whether GST offers better clinical outcomes and cost benefits compared to continued CBT-E, potentially influencing future standard care for chronic eating disorders.

CONDITIONS

Brief Title

Clinical and Cost-effectiveness of Group Schema Therapy for Complex Eating Disorders: the GST-EAT Study

Who Can Participate

Age: 16Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Age over 16 years
  • Diagnosis of anorexia nervosa, bulimia nervosa, or other specified eating disorder (including atypical anorexia nervosa or bulimia nervosa with low frequency or limited duration)
Not Eligible

You will not qualify if you...

  • Unable to speak and read Dutch language
  • Being in an acute psychotic mental health state at study start
  • Diagnosis of autism spectrum disorder
  • IQ below 80 as measured by a validated test
  • Showing early response after phase 1 of CBT-E

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Outpatient Treatment

Duration - Up to 39 weeks

Participants receive outpatient behavioral treatment for eating disorders. Group Schema Therapy (GST) includes 5 individual pre-group sessions, followed by 26 weekly group sessions and up to 8 optional individual sessions. Cognitive Behavioral Therapy-Enhanced (CBT-E) involves 20 to 40 weekly individual sessions.

Weekly visits for 20 to 40 weeks depending on assigned treatment

Follow-up

Duration - Up to 12 months after end of treatment

Participants are monitored for treatment outcomes and changes in symptoms for up to 12 months after treatment ends.

Visits at 6 and 12 months after treatment completion

Trial Site Locations

Total: 7 locations

1

GGz Breburg

Breda, Netherlands

Actively Recruiting

2

Accare

Groningen, Netherlands

Actively Recruiting

3

GGZ Friesland

Leeuwarden, Netherlands

Actively Recruiting

4

GGNet Amarum

Nijmegen, Netherlands

Actively Recruiting

5

GGz Breburg

Tilburg, Netherlands

Actively Recruiting

6

Co-eur

Utrecht, Netherlands

Actively Recruiting

7

GGNet Amarum

Warnsveld, Netherlands

Actively Recruiting

Loading map...

Research Team

J

Jeffrey Roelofs, Dr.

S

Suzanne Mares, Dr.

How is the study designed?

Study Type

INTERVENTIONAL

Masking

SINGLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Similar Trials

A Longitudinal Study of Severe and Enduring Eating Disorders

Eating Disorders

Actively Recruiting

1 location

Networks Integrating Anxiety and Metabolism in Human Anorexi...

Anorexia Nervosa

Actively Recruiting

1 location

Adapted Physical Activity Program Added to Usual Care for An...

Anorexia Nervosa

Actively Recruiting

7 locations

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Published Research Related To This Trial

Clinical effectiveness, cost-effectiveness and process evaluation of group schema therapy for eating disorders: study protocol for a multicenter randomized controlled trial.

Suzanne H W Mares, Jeffrey Roelofs, Janôt Zinzen...

https://pubmed.ncbi.nlm.nih.gov/38439092